Viewing StudyNCT00004635



Ignite Creation Date: 2024-05-05 @ 10:17 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004635
Status: COMPLETED
Last Update Posted: 2018-05-22
First Post: 2000-02-19

Brief Title: Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Organization Data

Organization: National Institutes of Health Clinical Center CC
Class: NIH
Study ID: 000080
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Cancer Institute NCI
Lead Sponsor Class: NIH
Responsible Party: William Dahut Jr MD
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: National Institutes of Health Clinical Center CC
Old Name: None
Old Organization: None

Collaborators

Name Class
Holy Cross Hospital Fort Lauderdale UNKNOWN
Louisiana State University Health Sciences Center in New Orleans OTHER
Wayne State University OTHER
University of Minnesota OTHER
Columbia University OTHER
University of Pittsburgh OTHER
United States Naval Medical Center Portsmouth FED
University of Washington OTHER